pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Oncology · news · pharmadog
← back to Oncology
News · Oncology
910
stories
Jul 2, 26
STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and more
stat
Jul 2, 26
STAT+: U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drug
stat
Jul 2, 26
STAT+: More frequent, more intense, and longer heat waves pose health risks for Americans
stat
Jul 2, 26
Roche’s KRAS G12C inhibitor beats rivals in head-to-head Phase 3 study
endpoints
Jul 2, 26
STAT+: Halfway into the year, biotech is booming
stat
Jul 2, 26
Opinion: CDC leadership continues to try to manufacture a scientific debate on vaccines where none exists
stat
Jul 2, 26
STAT+: A former AI regulator, now in industry, says biopharma is reading FDA’s guidance wrong
stat
Jul 2, 26
STAT+: A year after distressed buyout, what’s become of Bluebird Bio?
stat
Jul 1, 26
Statins and blood pressure drugs changing health risks of obesity, study suggests
stat
Jul 1, 26
FDA approves Orca Bio’s cell therapy to improve transplant outcomes
endpoints
Jul 1, 26
STAT+: Synthetic biology researchers think they’ve made a cell. Is it alive?
stat
Jul 1, 26
Ipsen to buy Swiss biotech Memo Therapeutics in potential $800M deal
biopharma dive
Jul 1, 26
STAT+: Pharmalittle: We’re reading about Anthropic drug development goals, Trump drug plan snags, and more
stat
Jul 1, 26
STAT+: More signs that GLP-1s may help with peripheral artery disease
stat
Jul 1, 26
Abivax shares surge as worries subside over immune drug’s cancer risk
biopharma dive
Jul 1, 26
FDA says Zyn can market its pouches as safer than cigarettes
stat
Jul 1, 26
STAT+: FDA approves Orca Bio’s T cell therapy for blood cancer patients
stat
Jul 1, 26
STAT+: Booze schmooze: The alcohol industry, frazzled by headwinds, wields its power behind the scenes
stat
Jun 30, 26
FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patients
fda press
Jun 30, 26
Ipsen’s $450M blood cancer drug; FDA selects first cohort for “pre-check” pilot program
biopharma dive
Jun 30, 26
AbbVie and Genmab's latest win brings Epkinly closer to label expansion
endpoints
Jun 30, 26
Abivax aims to set cancer concerns with ulcerative colitis drug to rest
endpoints
Jun 30, 26
These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.
biopharma dive
Jun 30, 26
Sarepta's FDA decision date; Flare gets Anna Protopapas as CEO
endpoints
Jun 30, 26
STAT+: FDA digital leader hints at coming AI policy updates
stat
Jun 30, 26
STAT+: Pharmalittle: We’re reading about Chinese trial sites being probed, RFK Jr. and peptides, and more
stat
Jun 30, 26
Half of states sue over Medicaid work requirements
stat
Jun 30, 26
STAT+: Abivax seeks to ease safety concerns with new data, boosting shares
stat
Jun 29, 26
STAT+: AstraZeneca to pay $34 million to settle kickback charges filed by Texas attorney general
stat
Jun 29, 26
FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufacturing
fda press
← prev
page 15 of 31
next →
